Preview Mode Links will not work in preview mode

Dec 15, 2021

Full article:

In patients at high risk for hepatocellular carcinoma, progression to higher categories from LR-2 and LR-3 observations remains a concern with surveillance of these lesions. Tune into this podcast to hear the results of a recently published study in AJR that found low progression rates of LR-2 and LR-3 observations with insights and comments from our special guest, the developer and leader of LI-RADS, Claude Sirlin, MD, who is an abdominal radiologist and professor at the University of California San Diego.